Comparative Pharmacology
Head-to-head clinical analysis: GEOPEN versus PENTIDS 800.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GEOPEN versus PENTIDS 800.
GEOPEN vs PENTIDS '800'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Carbenicillin is a bactericidal penicillin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. It has activity against Gram-negative and some Gram-positive bacteria.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), transpeptidases that catalyze the final transpeptidation step of peptidoglycan cross-linking, leading to cell lysis.
2 g intravenously every 6 hours for susceptible infections.
800 mg orally every 6 to 8 hours; maximum 4 g per day.
None Documented
None Documented
Terminal half-life 4-6 hours in normal renal function; prolonged to 10-20 hours in moderate renal impairment (CrCl 10-50 mL/min) and up to 30-50 hours in severe impairment (CrCl <10 mL/min).
0.5-1 hour; prolonged to 2-5 hours in renal impairment.
Renal: 80-90% unchanged via glomerular filtration and tubular secretion. Biliary/fecal: <2%.
Renal: ~60-85% unchanged via glomerular filtration and tubular secretion; Biliary: ~10%; Fecal: <5%.
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic